A world-first study trialing a new medication has shown to be life-changing for patients with Spinal Muscular Atrophy (SMA) like Xavier.
At the time when Xavier was born, his parents, Emily and Mitch, were only presented with two treatment options: a drug administered via an injection in the spine multiple times a year for the rest of his life, or a clinical trial testing a new medicine taken orally once a day.
Emily and Mitch enrolled Xavier in the RAINBOWFISH clinical trial testing an oral medication, risdiplam, in a cohort of 26 presymptomatic infants with SMA...
A groundbreaking clinical trial has transformed the future for children like Baby Flynn, born with a condition so rare that his parents, Sarah and Tim, didn't know what lay ahead.
A new world‑first therapy offered a lifeline for Flynn. An innovative approach designed specifically for infants diagnosed before symptoms emerge.
Flynn was among the first babies enrolled in a pioneering clinical trial, giving him access to a therapy that has already begun reshaping his early life, offering his family a hope they never expected...
A clinical trial did more than just offer treatment options for young Mateo, it also transformed his life for the better.
Mateo was a boy full of energy who enjoyed playing outside with friends. As he got older, his mum, Myra, noticed he stopped running around playing outside, and spent more time indoors playing video games.
Unknown to Myra, this change in Mateo’s behaviour was a symptom of a serious health condition...
A world-first clinical trial has given hope to children with arteriovenous malformations (AVMs), helping young people like Derek walk again.
Fourteen-year-old Derek first came to hospital when he started losing feeling in his hands and feet. He could barely walk or lift his arms, and breathing felt like it was through a straw. He was diagnosed with an arteriovenous malformation, a condition only helped by short-term stabilisation for serious symptoms.
Over time, as Derek's condition worsened, clinicians knew they needed a new approach...
How research is helping John stay stronger for longer
John was five years old when his parents noticed him limping. After taking him to their local paediatrician, he was diagnosed with Duchenne muscular dystrophy, a progressive genetic disorder that will leave him in a wheelchair by the time he reached adolescence.
With no cure, John's only treatment options are in research through clinical trials and frequent hospital visits. So far, he is responding well to the trial treatment, suggesting that he will stay stronger for longer...
Ten‑year‑old Nicholas and his family have navigated a long and difficult journey since he was first diagnosed with acute myeloid leukaemia. After enduring ten months of intensive chemotherapy and a bone marrow transplant, he spent most of that year in hospital and many more months at home in isolation to protect his fragile immune system.
Their world shifted again three years later when a routine biopsy showed that Nicholas’ cancer had returned, bringing back uncertainty and fear. With limited options left, the family turned to a new precision medicine approach that offered renewed hope...
